What changed
DexCom, Inc. appointed Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Boehnlein served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025, bringing more than 20 years of medical technology industry experience. His expertise spans financial leadership, capital allocation, strategic M&A, and operational excellence as Dexcom executes its newly announced long-range plan.
Why it matters
DexCom, Inc. appointed Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Boehnlein served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025,